PEEP changes
ProcedureAll patients will be ventilated with a tidal volume of 6 ml/kg before the RRI assessment. Further, three level of PEEP (5, 10 and 15 cmH2O) will be randomly set. For each levels of PEEP, the RRI will be evaluated
NCT Number: NCT03969914
The renal Doppler resistive index (RRI) is a noninvasive tool that has been used to assess renal perfusion in the intensive care unit (ICU) setting. Many parameters have been described as influential on the values of renal RI. Mechanical ventilation is associated with significant increases in the risk of acute kidney injury (AKI). Ventilator-induced kidney injury (VIKI) is believed to occur due to changes in hemodynamics that impair renal perfusion. The investigators hypothesized that patients who need mechanical ventilation should have a different response in RRI when different levels of Positive end expiratory pressure (PEEP) are applied. Investigators wish to describe changing in RRI due to changes in PEEP and to verify whether these changes could partially explain the occurrence of VIKI
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Università di Ferrara, Ferrara, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All patients will be ventilated with a tidal volume of 6 ml/kg before the RRI assessment. Further, three level of PEEP (5, 10 and 15 cmH2O) will be randomly set. For each levels of PEEP, the RRI will be evaluated
Time frame: once a day until day 7
AKI will be defined according to Kidney Disease: Improving Global Outcomes (KDIGO) criteria
Time frame: One a day until day 5
To compare median difference of RRI at PEEP 5 and PEEP 15 in patients who will develop (or not) AKI
Università degli Studi di Ferrara
Other
Acronym: PRE-VIKI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00458926
Asthma, Bronchial Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT01374022
Lung Diseases, Pathologic Processes
São Paulo, Brazil
View Trial DetailsNCT00416260
Lung Diseases, Pathologic Processes
Athens, Attica, Greece
View Trial DetailsNCT01119872
Lung Diseases, Pathologic Processes
Alcalá de Henares, Madrid, Spain
View Trial Details